[HTML][HTML] Androgen receptor: a potential therapeutic target for glioblastoma
N Zalcman, T Canello, H Ovadia, H Charbit…�- Oncotarget, 2018 - ncbi.nlm.nih.gov
N Zalcman, T Canello, H Ovadia, H Charbit, B Zelikovitch, A Mordechai, Y Fellig, S Rabani…
Oncotarget, 2018•ncbi.nlm.nih.govAndrogen receptor: a potential therapeutic target for glioblastoma - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content
Main Navigation Preview improvements coming to the PMC website in October 2024. Learn
More or Try it out now. Search PMC Full-Text Archive Search in PMC Advanced Search User
Guide Journal List Oncotarget v.9(28); 2018 Apr 13 PMC5929440 Other Formats PDF (2.7M)
Actions Cite Collections Share Permalink Copy RESOURCES Similar articles Cited by other�…
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content
Main Navigation Preview improvements coming to the PMC website in October 2024. Learn
More or Try it out now. Search PMC Full-Text Archive Search in PMC Advanced Search User
Guide Journal List Oncotarget v.9(28); 2018 Apr 13 PMC5929440 Other Formats PDF (2.7M)
Actions Cite Collections Share Permalink Copy RESOURCES Similar articles Cited by other�…
Abstract
The median survival time of patients with glioblastoma is still poor (14.6 month), partly due to a lack of effective treatment.
ncbi.nlm.nih.gov